Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
William J. PetersCFO, EVP & Treasurer | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 09/21 | 09/23 | 4,139 sh | $25.00 | $103,475 | −2.4% |
Rong ZhouSenior EVP, Production Center | Amphastar PharmaceuticalsAMPH | Open-market sale | 25/12/17 | 25/12/18 | 9,787 sh | $26.20 | $256,419.4 | −6.6% |
Amphastar PharmaceuticalsAMPH | Open-market sale | 25/12/11–25/12/12 | 25/12/15 | 4,163 sh2 trades | $25.82avg. | $107,505.45 | −5.5% | |
Richard K. PrinsDirector | Amphastar PharmaceuticalsAMPH | Open-market sale | 25/11/25 | 25/11/25 | 4,179 sh | $27.10 | $113,250.9 | −10.6% |
Floyd F. PetersenDirector | Amphastar PharmaceuticalsAMPH | Open-market sale | 25/11/13 | 25/11/17 | 16,679 sh | $26.49 | $441,826.71 | −18.1% |
Floyd F. PetersenDirector | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 25/11/03 | 25/11/05 | 500 sh | $25.27 | $12,635 | −0.7% |
Floyd F. PetersenDirector | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 25/10/01 | 25/10/02 | 500 sh | $27.20 | $13,600 | −0.7% |
Floyd F. PetersenDirector | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 25/09/02 | 25/09/03 | 500 sh | $30.98 | $15,490 | −0.6% |
Floyd F. PetersenDirector | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 25/08/01 | 25/08/04 | 500 sh | $20.83 | $10,415 | −0.6% |
Floyd F. PetersenDirector | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 25/07/02 | 25/07/03 | 500 sh | $23.47 | $11,735 | −0.6% |
Floyd F. PetersenDirector | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 25/06/02 | 25/06/04 | 500 sh | $25.67 | $12,835 | −0.7% |
Floyd F. PetersenDirector | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 25/05/01 | 25/05/02 | 500 sh | $24.08 | $12,040 | −0.7% |
Floyd F. PetersenDirector | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 25/04/01 | 25/04/02 | 500 sh | $28.38 | $14,190 | −0.7% |
Floyd F. PetersenDirector | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 25/03/06 | 25/03/07 | 1,000 sh | $27.99 | $27,990 | −1.3% |
William J. PetersCFO, EVP & Treasurer | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 25/03/04 | 25/03/06 | 4,231 sh | $27.54 | $116,521.74 | −4.2% |
Amphastar PharmaceuticalsAMPH | Open-market sale | 24/12/12–24/12/13 | 24/12/16 | 15,000 sh2 trades | $44.86avg. | $672,850 | −11.2% | |
Richard K. PrinsDirector | Amphastar PharmaceuticalsAMPH | Open-market sale | 24/12/09 | 24/12/11 | 10,000 sh | $43.77 | $437,700 | −24.7% |
Richard K. PrinsDirector | Amphastar PharmaceuticalsAMPH | Open-market sale | 24/11/12 | 24/11/13 | 5,000 sh | $48.80 | $244,000 | −13.7% |
Rong ZhouSenior EVP, Production Center | Amphastar PharmaceuticalsAMPH | Open-market sale | 24/11/12 | 24/11/13 | 6,893 sh | $48.88 | $336,929.84 | −5.5% |
William J. PetersCFO, EVP & Treasurer | Amphastar PharmaceuticalsAMPH | Open-market sale10b5-1 plan | 24/11/06 | 24/11/08 | 7,426 sh | $52.05 | $386,523.3 | −7.3% |